A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
| 148.15 | Mitochondrial toxins, | 1-methyl-4-phenylpyridinium (MPP+) and 3-nitropropionic acid, inhibit produ |
| 150.11 | Decreased cortical | 11C-flumazenil uptake following temporary middle cerebral artery occlusion |
| 017.6 | r morphology is severely affected in the beta, beta-carotene-15, | 15'-dioxygenase zebrafish morphant |
| 224.6 | 1, 25-Dihydroxyvitamin D3 (1, 25-D3) and | 17beta-estradiol (E) reduce infarct size and heme oxygenase-1 (HO-1) upregu |
| 224.6 | 1, | 25-Dihydroxyvitamin D3 (1, 25-D3) and 17beta-estradiol (E) reduce infarct s |
| 024.19 | T) expression during circadian rhythm; Binding of hnRNP R to the | 3'UTR mediates rapid turnover of AA-NAT mRNA |
| 223.19 | Uridine release during | 3-aminopyridine-induced epilepsy |
| 114.3 | Central AMPA-antagonist effect of some 2, | 3-benzodiazepine-type GYKI-compounds |
| 174.3 | Inhibition of | 3-beta-hydroxysteroid sulfatase in the hippocampus is involved in spatial m |
| 054.7 | the novel poly(ADP-ribose) polymerase (PARP) inhibitor thieno[2, | 3-c]isoquinolin-5-one(TIQ) : neuroprotective effects in models of cerebral |
| 082.10 | potentiation in the dentate gyrus of rat hippocampus in vivo: a | 3-dimensional quantitative study |
| 184.3 | Different views on the same thing: | 3-dimensional tracing of intrinsic and thalamic connections of the Mongolia |
| 078.18 | 3-Hydroxybutyrate alters GABA-A receptor kinetics in rat neocortical pyrami | |
| 226.6 | pain in striatal degeneration induced by the mitochondrial toxin | 3-nitropropionic acid |
| 091.9 | opamine is involved in the neurotoxic action of quinolinic acid, | 3-nitropropionic acid and MPP+ lesions of striatal neurons in the rat |
| 091.13 | motor behavioural deficits and increased striatal sensitivity to | 3-nitropropionic acid in dopamine transporter knock-out mice |
| 054.11 | The mitochondrial toxin, | 3-nitropropionic acid induces striatal neurodegeneration via a c-jun n-term |
| 056.20 | Study of the effect of nomifensine on the | 3-nitropropionic acid toxicity in rat striatum |
| 148.15 | Mitochondrial toxins, 1-methyl-4-phenylpyridinium (MPP+) and | 3-nitropropionic acid, inhibit production of glutamate receptors antagonist |
| 049.1 | Effects of antipsychotics on | 3H-dopamine uptake in rat striatal membranes |
| 146.20 | Activation of nicotinic acetylcholine receptors modulates | 4-aminopyridine induced epileptiform activity in rat hippocampal slices |
| 223.9 | Epileptiform activity induced by | 4-aminopyridine is associated with Mitogen-Activated Protein Kinase ERK act |
| 223.5 | lvement of potassium and gap-junctions in the synchronization of | 4-AP induced GABAergic activity in human epileptic neocortex |
| 206.5 | The inhibitor of protein tyrosine phosphatases Et-3, | 4-dephostatin mimics NGF-induced neuroprotective signaling |
| 153.6 | xis and sympathetic activity on neurochemical consequences of 3, | 4-methylenedioxymethamphetamine (MDMA, ecstasy) administration in Fischer 3 |
| 114.16 | Neuronal Calcium Sensor 1 interacts with phosphatidylinositol | 4-OH kinase-beta in rat neurons and neuroendocrine cells: functional implic |
| 056.13 | Effect of chronic administration of 1, 2, 3, | 4-tetrahydroisoquinoline (TIQ) under conditions of CYP2D enzymes blockade o |
| 157.16 | The effect of endogenous neurotoxin 1, 2, 3, | 4-tetrahydroisoquinoline on noradrenaline metabolism and arterial blood pre |
| 215.5 | Isolation and characterization of the | 5'-flanking region of the human serotonin 5-HT4 receptor gene |
| 142.10 | ged rats: The effect of cholinergic agents on performance of the | 5-choice serial reaction time task |
| 210.14 | effects of repeated administration of amphetamine and cocaine on | 5-choice serial reaction time task performance in rats |
| 142.9 | Assessing a vigilance decrement in the | 5-choice serial reaction time task: Effect of age, pre-feeding, task manipu |
| 210.4 | selective ligand with Chlordiazepoxide and Lorazepam in the rat | 5-choice serial reaction time test |
| 210.1 | tine in rats trained to respond with different reaction times in | 5-CSRTT |
| 207.1 | 5-HT descending inputs control the maturation of the GABAergic neuronal pop | |
| 116.13 | 5-HT induced network-activity causes bidirectional plasticity in the develo | |
| 122.13 | ffects of paroxetine and tranylcypromine on the rat dorsal raphe | 5-HT neuronal activity: an effect mediated via 5-HT2 or 5-HT7 receptors |
| 122.2 | Comparison of adaptive changes in | 5-HT receptor subtypes in frontal cortex and hippocampus evoked by repeated |
| 038.2 | 5-HT receptors subtypes involved in the regulation of adult neurogenesis in | |
| 122.3 | Control of | 5-HT release in the dorsal raphe nucleus by the noradrenergic system in rat |
| 049.3 | Functional consequences of strain differences in hippocampal | 5-HT transporter in male and female Fischer 344 and Lewis rats |
| 107.19 | Effects of serotonin ( | 5-HT) 1b receptor ligands microinjected into the ventral tegmental area on |
| 175.19 | Serotonin ( | 5-HT) 1b receptors in the ventral tegmental area control the cocaine-evoked |
| 215.10 | egulation of serotonergic-neuron firing by endogenous serotonin ( | 5-HT) and 5-HT releasers in the rat Dorsal Raphe Nucleus |
| 088.15 | asing hormone (CRH) antagonist R121919 on hippocampal serotonin ( | 5-HT) and hypothalamic-pituitary-adrenocortical (HPA) axis activity in mice |
| 070.1 | Modulation of electrically evoked 5-hydroxytryptamine ( | 5-HT) release in cultured neurons of the rat fetal raphe region |
| 175.3 | ot reveal concomitant alterations of dopamine (DA) or serotonin ( | 5-HT) transmission in ventral hippocampal projection areas |
| 227.1 | 5-HT-induced locomotor-like activity in the isolated rat spinal cord: evide | |
| 046.12 | 5-HT-mediated regulation of GABA output from dendrites of local thalamic in | |
| 122.4 | Gender-dependent desensitization of | 5-HT1A autoreceptors in knock-out mice deficient in the 5-HT transporter |
| 050.2 | 5-HT1B but not 5-HT1A receptors mediate 5-HT-induced antinociceptive effect | |
| 107.31 | Effect of intraseptal injections of the | 5-HT1A agonist 8-OH-DPAT on spatial memory in the rat |
| 175.6 | lication in anti-anxiety mechanisms: an intracerebral study with | 5-HT1A agonist buspirone perfusion into the amygdala in mice |
| 055.11 | of monoaminoxidase A knockout on the hypothermic response to the | 5-HT1A agonists and ethanol |
| 215.7 | Targeting of serotonin | 5-HT1A and 5-HT1B receptors : In vitro and in vivo non viral gene transfer |
| 145.3 | eCFP- and eYFP- tagged serotonin | 5-HT1A and 5-HT1B receptors : targeting in epithelial and neuronal cells |
| 122.4 | Gender-dependent desensitization of | 5-HT1A autoreceptors in knock-out mice deficient in the 5-HT transporter |
| 213.1 | Repressor elements for cell-specific expression of the human | 5-HT1a gene |
| 123.15 | Effects of | 5-HT1A receptor activation on adrenergic system in discrete areas of the ra |
| 154.4 | Effects of the | 5-HT1A receptor agonist flesinoxan in C57BL/6J and 129S6/SvEvTac mice in th |
| 078.3 | pine resistant/ sensitive anxiety in outbred and inbred lines of | 5-HT1a receptor knockout mice |
| 175.27 | Activation of post-synaptic | 5-HT1A receptors in rat prefrontal cortex selectively enhances accuracy on |
| 160.3 | 5-HT1A receptors in the budgerigar brain (Melopsittacus undulatus) in the b | |
| 175.17 | Involvement of | 5-HT1A receptors in the regulation of circadian rhythms |
| 050.2 | 5-HT1B but not | 5-HT1A receptors mediate 5-HT-induced antinociceptive effects in the formal |
| 215.6 | Decreased | 5-HT1A-mediated G protein dependent potassium current in dorsal raphe neuro |
| 151.8 | Reduction of | 5-HT1B and 5-HT6 receptor density in the frontal (BA10) and temporal (BA20) |
| 050.2 | 5-HT1B but not 5-HT1A receptors mediate 5-HT-induced antinociceptive effect | |
| 215.7 | Targeting of serotonin 5-HT1A and | 5-HT1B receptors : In vitro and in vivo non viral gene transfer to neurons |
| 145.3 | eCFP- and eYFP- tagged serotonin 5-HT1A and | 5-HT1B receptors : targeting in epithelial and neuronal cells |
| 159.15 | in effects on visual receptive fields in superior colliculus via | 5-HT1B receptors, studies in wildtype and 5-HT1B knockout mice |
| 122.13 | rat dorsal raphe 5-HT neuronal activity: an effect mediated via | 5-HT2 or 5-HT7 receptors |
| 180.15 | 5-HT2 receptor induced spinal reflex plasticity: mechanisms of long-term mo | |
| 175.12 | Reduced sensitivity to psychotomimetic drugs in mice lacking the | 5-HT2A receptor |
| 175.21 | ing of rats leads to a differential increase in frontal cortical | 5-HT2A receptor density |
| 190.2 | Activation of | 5-HT2A receptors and thalamic disinhibition increase the discharge rate of |
| 156.12 | Cellular and subcellular localization of | 5-HT2A receptors in the ventral horn of the rat spinal cord |
| 011.16 | tial co-localisation of parvalbumin and calbindin with serotonin | 5-HT2A receptors on GABAergic neurons in rat anterior and posterior frontal |
| 215.2 | The induction of c-Fos proteins in the rat cortex by DOI, | 5-HT2A/2C receptors agonist is modulated by arachidonic acid/cyclooxygenase |
| 154.12 | The role of the | 5-HT2C receptor in unconditioned escape responses in the unstable elevated |
| 215.8 | Synaptic multiprotein complexes associated with | 5-HT2C receptors: a proteomic study |
| 090.10 | Involvement of | 5-HT3 and 5-HT4 receptors in gastrointestinal transit in mice |
| 122.11 | Functional antagonism of antidepressants at the | 5-HT3 receptor |
| 015.15 | aptic excitation of neocortical VIP/CCK interneurons mediated by | 5-HT3 receptors |
| 123.3 | n of the baroreflex bradycardia during defense reaction involves | 5-HT3 receptors in the nucleus tractus solitarius (NTS) |
| 215.3 | Characteristics of cloned | 5-HT3A(s) receptor topology in transfected hippocampal neurons |
| 090.13 | Three new benzimidazole derivatives as selective and orally | 5-HT4 receptor antagonists |
| 215.5 | haracterization of the 5'-flanking region of the human serotonin | 5-HT4 receptor gene |
| 215.4 | of interactions between transmembrane domains III and VI of the | 5-HT4 receptor is required for the activity of inverse agonists but not ago |
| 151.18 | The human serotonin | 5-HT4 receptor regulates secretion of non Amyloidogenic Precursor Protein |
| 215.15 | Cloning of a novel human serotonin | 5-HT4 receptor splice variant lacking the alternative C-terminal exon. Dist |
| 090.10 | Involvement of 5-HT3 and | 5-HT4 receptors in gastrointestinal transit in mice |
| 142.16 | Agonist (RS67333) and antagonist (RS 67532) | 5-HT4 receptors in learning and long-term memory : a behavioral and electro |
| 022.9 | Distribution of | 5-HT4a and 5-HT7 receptors in rodent brain |
| 215.9 | Differences in pharmacology and CNS distribution of the mouse | 5-HT6 receptor compared to the human and rat 5-HT6 receptors |
| 151.8 | Reduction of 5-HT1B and | 5-HT6 receptor density in the frontal (BA10) and temporal (BA20) cortex in |
| 151.1 | Immunocytochemical localization of the | 5-HT6 receptor in control and Alzheimer brains |
| 122.13 | al raphe 5-HT neuronal activity: an effect mediated via 5-HT2 or | 5-HT7 receptors |
| 022.9 | Distribution of 5-HT4a and | 5-HT7 receptors in rodent brain |
| 038.4 | or cells (NPC) derived from adult serotonin transporter KO mice ( | 5-HTT KO) than in NPC from wild-type mice : An in-vitro study on the impact |
| 215.6 | ependent potassium current in dorsal raphe neurones of knock-out | 5-HTT-/- mice |
| 070.1 | Modulation of electrically evoked | 5-hydroxytryptamine (5-HT) release in cultured neurons of the rat fetal rap |
| 084.19 | Therapeutic potential of selective | 5-hydroxytryptamine 2A receptor inverse agonists: Pre-clinical evaluation o |
| 057.6 | Inhibition of | 5-hydroxytryptamine synthesis increases d-amphetamine evoked release of nor |
| 046.10 | Photoliberating inositol-1, 4, | 5-triphosphate (IP3) triggers the release of ATP in brain endothelial cells |
| 138.15 | Signal transduction mechanism(s) of extracellular guanosine | 5-triphosphate in PC12 cells |
| 185.15 | 5HT action on periglomerular neurons in rat olfactory bulb slices: Electrop | |
| 007.23 | terning in mouse somatosensory cortex is modulated by serotonin ( | 5HT) : study in monoamine oxydase A (MAOA) knockout and MAOA/5HT1B receptor |
| 015.22 | transmission in hippocampal CA1-neurons by different serotonin ( | 5HT) receptors |
| 110.4 | us transmission in transgenic mice with an overexpression of the | 5HT1a receptor gene |
| 215.12 | Ultrastructural localization of | 5HT1B serotonin receptors in the rat hippocampal CA1 and CA3 regions: relat |
| 212.8 | Differential proteomic analysis of | 5HT7 knockout and wild type mice |
| 226.22 | ophysiological studies of chemical lesioned nucleus accumbens by | 6-0HDA in morphine treated rat |
| 186.6 | The assessment of | 6-fluorodopamine as a potential neurotoxin to establish a new rat model of |
| 045.16 | ssion of peptide immunoreactivity in pallidal neurones following | 6-hydroxydopamine lesion of the substantia nigra |
| 056.7 | ole of dopamine system in caffeine sensitization in unilaterally | 6-hydroxydopamine lesioned rats |
| 175.26 | ethacin protects against self-stimulation impairment produced by | 6-hydroxydopamine lesions in the rat |
| 186.12 | 6-hydroxydopamine-induced cell death: involvement of oxidative stress and a | |
| 018.15 | cellular space diffusion parameters in the striatum of rats with | 6-hydroxydopamine-induced lesions and with fetal mesencephalic grafts |
| 053.9 | vesicular monoamine transporter 2 (VMAT2) by reserpine enhances | 6-hydroxydopamine-induced toxicity while hypothermia completely prevents it |
| 018.18 | symptomatic and neuroprotective actions in the substantia nigra | 6-OHDA lesion model |
| 155.7 | c dopaminergic neurons infected, ex-vivo, with an HSV-GDNF, in a | 6-OHDA rat model of Parkinson's disease |
| 186.9 | What does SNc versus VTA | 6-OHDA-induced lesion to cortical dopaminergic innervation |
| 077.12 | 7-nitroindazole, a selective neuronal nitric oxide synthase inhibitor in vi | |
| 121.25 | 7-Nitroindazole, an inhibitor of neuronal nitric oxide synthase, facilitate | |
| 175.7 | Modifications induced by | 7-OH-DPAT, a D3 dopamine receptor agonist, on orienting motor response, in |
| 033.2 | The serotonin1A-receptor agonist | 8-OH-DPAT inhibits cocaine-induced serotonin release in the hippocampus and |
| 107.31 | Effect of intraseptal injections of the 5-HT1A agonist | 8-OH-DPAT on spatial memory in the rat |
| 192.10 | Increase in the DNA repair protein, | 8-oxoguanine DNA glycosylase 1 (Ogg1), after stress immobilization and duri |